SCHEMBL6351822

SCHEMBL6351822

N#Cc1ccc(NC(=O)c2cccc(SCc3ccccc3)c2)c(C(=O)O)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 3/20 0.59
MCL1 Q07820 2/20 0.55
BCL2A1 Q16548 2/20 0.55
LTC4S Q16873 1/20 0.48
KMT2A Q03164 7/20 0.47
MEN1 O00255 6/20 0.46
PKM P14618 1/20 0.46
ALDH1A1 P00352 2/20 0.46
LMNA P02545 2/20 0.46
HPGD P15428 2/20 0.46
KDM4E B2RXH2 3/20 0.46
GFER P55789 1/20 0.46
ALB P02768 2/20 0.45
MAOA P21397 1/20 0.45
MAOB P27338 1/20 0.45
MAPT P10636 3/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2C19 P33261 1/20 0.45
NPSR1 Q6W5P4 2/20 0.45
SERPINE1 P05121 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6346632 0.92 SIRT2 (0.56) SIRT2MCL1BCL2A1LTC4SKMT2A
Hydrochloric Acid SCHEMBL6350733 0.91 SIRT2 (0.55) SIRT2MCL1BCL2A1LTC4SKMT2A
SCHEMBL6350712 0.84 AKR1C2 (0.63) MCL1BCL2A1LTC4SKMT2AMEN1
SCHEMBL6353963 0.82 KMT2A (0.62) MCL1BCL2A1LTC4SKMT2AMEN1
SCHEMBL6349884 0.81 SMPD1 (0.61) KMT2AMEN1ALDH1A1MAOBAKR1C2
SCHEMBL6818090 0.81 ALB (0.65) MCL1BCL2A1LTC4SKMT2AMEN1
Hydrochloric Acid SCHEMBL6833139 0.80 ALB (0.64) MCL1BCL2A1LTC4SKMT2AMEN1
SCHEMBL6359203 0.80 KMT2A (0.58) LTC4SKMT2AMEN1PKMALDH1A1
SCHEMBL6351469 0.80 AKR1C2 (0.66) LTC4SKMT2AMEN1PKMALDH1A1
SCHEMBL6352168 0.80 KMT2A (0.47) SIRT2MCL1BCL2A1LTC4SKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US claimed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO claimed
US-20050113450-A1 Antibacterial agents PHARMACIA & UPJOHN COMPANY 2005-05-26 US disclosed
WO-2004018414-A2 ANTIBACTERIAL AGENTS PHARMACIA & UPJOHN COMPANY LLC (US) 2004-03-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050113450-A1 Antibacterial agents CLPP, SPOUT1, SAMHD1 SIRT2 3380/4885MCL1 2360/4885BCL2A1 1379/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.